µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º <P~pn!F}
w"{mDL}c
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ |"g+p)A
H
S)$|m_
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) s}q tM.^W
,n{R,]y\
1. ICAM-1 yXQ 28A
+;T\:'CU
2. interleukin 12(IL-12) #(}'G*
&'k
:?@J[
3. tumor infiltrating lymphocyte 068DC_
oT0:Ny
4. TCR/CD3 complex c
HC1l
;b}cn!U]
5. hematopoietin receptor family @ 3rJ $6W
h t3P@;
6. individual idiotype(IdI) OP|X-
!5
?<QKOe
7. integrin RR2M+vQ
(&-I-#i
8. colony-stimulatory factor (CSF) {A~3/M%74;
P~84#5R1
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© %?3$~d\n
[HhaBy9
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? :Wihb#TO)
M?5v oV*
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ Yyw9IYB;
.pG`/[*a
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠsf
O{.#5<
x\IuM
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ *x_e] /}
n\< uT1n
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) c_t7<
<kJ`qbOU
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ ,Iru_=Wk~
3lbGG42:
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) 7X8*7'.2
nt@uVwfQ
3. immunoglobulin superfamily (IgSF) "MD6 <H
e:K'e2
4. selectin (,tL(:c
{P
3gMv;
5. anti-idiotypic antibody (¦ÁId) ol~ tfS
RRro.r,
6. major histocompatibility complex(MHC) |"[;0)dw^
$KBW{
7. immunotolerance aWNjl
t~
$8sG\
8. biological reponse modifier(BRM) B`w8d[cL7
G
*<g%"
9. immune reponse gene (Ir gene) D&=+PAX
><$V:nsEO
10. reshaped antibody (or reconstituted antibody) =@&>r5W
1
p} JGx^X~
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© '+GY6Ecg
3#aLCpVla
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ =BbXSwv'(
PP/#Z~.M
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? GnCs_[*&r
1(Z+n,Hh
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ We*uZ?+
Q(R-8"
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? ?0-3J )kW
l\!`ZhM,
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ 9!0-~,o
tOZ-]>U
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? YgtW(j[
3Vk\iJ
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ ma/<#l^}
sQ&<cBs2
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ 4^9qs%&
"Y"`'U=v
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? Hq&MePl[
*|cs_,3
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ oW>e.}d!
xa967Ki9"
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: P,7R/-u 5D
uLfk>&hc
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: V0*MY{x
#S
@PK
1
̉񧄤 0LTsWCUQ6e
"|N0oEG&
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© i3)7Qa[
dZddoz_
1. CD8 LaL{
^wP
8M]QDgd.
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) ty@D3l
R <&U]%FD
3. immunoglobulin fold(Ig fold) )Ofwfypc
YllW2g:
4. cadherin (Ca-dependent cell adhesion moleculers) q AsTiT6r
f'tQLF[r<
5. idiotype-anti-idiotypic antibody immune network theory d_&~^*>
$ dKo}
6. HLA class II antigen #8%~ u+"N
R-2Abyts2
7. complementarity-determining region (CDR)
BDX>J3h
/<J5?H
8. perforin(or pore-forming protein ,PFP) Bi0&F1
ZC!
b86c[2
9. high affinity IL-2 receptor }!WuJz"
N0YJ'.=8,
10. artificial active immunization ?9~|K/ `l
bV*q~@xh
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© /g!X[rn7Q
uK[gI6M
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠg{hbq[>X]
#* 8^ar<
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 Gd|jE
R1/mzPG
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ uzT>|uu$
bGik~
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ h3p~\%^
rWp+kV[Ec>
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ |+1k7S,
CSr2\ogT
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? )!sjXiC!h
T6=~vOzTJ
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ "@itn
?Lr:
>
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ 2K2*UC`f
K` <`l
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ :]`JcJ
eGI&4JgJ.
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ (U*Zz+ R
/ KKA/
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© uJJP<mDgA
U5j0i]
1. immunoglobulin gene rearrangement XK
yW
)GJlQ1x
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) 0Pg@%>yb~
!jN$U%/,%.
3. flow cytometry(FCM) ^ANz=`N5,
/O$)m[
4. carrier effect fXAD~7T*s
*
Vymb
5. positive selection of T lymphocytes in thymus BWsD~Ft
[Mlmn$it
6. mouse TH1(Th1) and TH2(Th2) subsets T`) uR*
$
fq0[7Yb
7. perforin (pore-forming protein ,PFP) =L}$#Y8?
76S>xnN
8. ADCC(antibody-dependent cell-mediated cytotoxicity) |r53>,oR<:
S3YAc4
9. SH-2(src-homology region 2) |1Ko5z
BsN~Z!kd
10. Ab2¦Â (internal image) )"y]_}
Py#iC#g~
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© "C [uz&
m{0u+obi&w
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? ,
-S n
~8G cWy6
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? |n.ydyu`
h3kBNBI )
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠWFFpW{
WWWfQ_u2
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ 0qD.OF)8
!<MW*7P=
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠDR#[\RzNI
DX#F]8bWl
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) j~rarR@NB)
9:6
d,^X
ÃâÒßѧרҵ£º 7S9Q{
wenJ (0L|
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ Y{ 2xokJ N
j<*`?V^
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? <x2 F5$@
)Z2t=&Nw
´«È¾²¡Ñ§×¨Òµ£º t~"DQqE
)?PRG=
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ ._z[T@!9
6 _\j_$
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ ?YbZVoD)J
A?829<
Ïû»¯×¨Òµ£º CDM==Xa*
mF !=H%
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ 3
,?==?
gJ>HFid_C
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? L)ry!BuHI
o<-+y\J8K
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ ?V&[U
sIJ37;ZA
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 8W_X&X?Q
bz?
*#S
1. Fas(CD95)/FasL h&6x.ps@
8Cr?0Z
2. common chain of cytokine receptor jP";ll|c
qlg~W/
3 . TCR/CD3 complex P!";$]+
f(E 'i>
4. negaive selection of thymocytes s"|N-A=cS
ngJES`0d
5. artificial active immune "zO+!h'o
J)n g,i
6. anti-idiotypic !2N#H~{
1q!6Sny@
7. IgSF f:TC;K
BI=Ie?
8. Integrin 8C=Y(vPk2
%;PPu$8K9
9. chemokine T+2I:W%
1W
HR;!u
10. B7/CD28 $/45*
9ffRY,1@
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© zq]V6.]J
3<msiCP
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ @Cm"lv.hz
a(8]y.`Tv
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ 'eqvK|Uj:
AJ:@c7:eS
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ $X~=M_W
lLtC9:
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ Ze Shn
g)&-S3\
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ /IV:JVT
{Rw~G&vQ
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ D?5W1m]E,s
GJy,)EO6{
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© Z@C
D1+ G
R?|_`@@A
1. B7/CD28 YN>#zr+
~
Cv$TNkP*
2. Th1 subset Z^
G
riL
'T|.<u@~
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© n{'
[[2U
qs-:JmA_w
4. antibody affinity maturation X?7$JV-:
R?&S]?H
5. AP-1 6gR=
e+
Y?%6af+
6. single chain variable fragment£¨ScFv£© KP<J~+_ik
A<.Q&4jb
7. NK cell receptor M;43F*
Yaa
M-o
8. Zinkernagel-Doherty phenomenon 8v]{ 5
VJR'B={h
9. Ig fold WVNQ}KY
[#9ij3vxd
10. CD40/CD40L Rthu8NKn
'Ux_X:,:;
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© R<U?)8g,h~
xwRnrWd^6
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ 'Vrev8D
=AKW(v
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ BO9Z"|"
5r+0^UAO:J
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ Uv+pdRXn
l.34
h
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ U|Jo[4A
n]$vCP
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ no/]Me!j=
tm|lqa
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ XsG]-Cw
eY(usK
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ 18n84RkI9
}agl:~C
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© asq/_`
52["+1g\
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 5{u6qc4FW
c0qv11,:t
1.Co-stimulators (or co-stimulating molecules) 8;!Eqyt
C5WCRg5&
2.NK-kB EU@mrm?
Gzir>'d2'V
3.Immunoglobulin superfamily Xou#38&p>
|ber:1
4.antigen-presenting cell (APC) |O)deiJRy
<bx9;1C>zd
5.death domain .#:,j1L"53
`HM3YC
6.CCR and CXCR hY1|qp
L@z !,r,
7.Lectin (or mitogen) ];I| _fXo%
XsOOkf\_
8.Clusters of differentiation, CD) ob] lCX)
|tg?b&QR
9.B7 family FR}H$R7#
2&Byq
10.Cytotoxic T lymphocyte, CTL) ^c\ IZ5
&
.?HuK
11.IL-15 and IL-15 receptor (IL-15R) @:7gHRJ!
$CmX
&%L=
12.MHC restriction IPO[J^#Me
~& 5&s
13.Affinity-chromatography A&P1M6Of
{}pqxouE
14.Cyctosprin A, CsA +?iM$}8!U
@ >(u:.
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) eUkoVr
y"\,%.
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© }%YHm9)
^Q=y^fx1
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 /Tj"Fl\h
r.W,-%=bL
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ $G_Q`w=jM
>J}n@MZ
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ bV`C;RPn
bw<w
u}ED
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© v1r_Z($
)E:,V~< 8
ÃâÒßѧרҵ£º cH;TnuX
YvruK:I
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ g6g$nY@Jm
3l%,D:
?
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ?{: D,{+
o}=.
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ v'@b. R,
(
f,J_
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) iS"8X#[]N
ISS\uj63M
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) rer|k<k;]G
*AH^%!kVP
1. ADCC(antibody dependent cell-mediated cytotoxicity) xHB/]Vd-
nMGrG
2. »·æß¾úËØ(cyclosporin) JzMZB"Z?
#9`r XEz
3. KIR(killer cell inhibitory receptor) B:-U`CHHQ
4TUtY:
4. HLDA(human leucocyte differentiation antigen) e40udLH~x
$J"%I$%X=
5. Interleukin 18(IL-18) YOV :
7qg<[
6. ÕûºÏËØ(integrin) W|d
pFh`
94|yvh.B
7. Fas/FasL 8/3u/
H&X:!xa5
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) aDL)|>"Q
tAqA^f*{
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) f=ac I|w
)N(9pnyZH
10. Th1/Th2 dEA
SvD'
G#H9g PY
11. »ùÒòÒßÃç(DNAÒßÃç) RF_[?O)Q
qy_%~c87
12. chemokines and chemokine receptor i&`!|X-=R
I%@e
@Dm,h
13. ÃâÒßÄÍÊÜ pW\z\o/2
ITyzs4"VV
14. ¹²´Ì¼¤·Ö×Ó } ^"0T-ua
#?9Q{0e
15. ËÀÍö½á¹¹Óò(death domain) S%kS#U${|
U98_M)-%&
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) -!cIesK;<
9\v.qo.
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? 0[/vQ+O ]2
14H'!$
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠtd >,TW=A*
lop uf/U0
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î b,dr+RB
P@gtdi(Q
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ cC%j!8!
%M9;I
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå x;j{}
%
EJLQ&oH[
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ Cxm6TO`-;
?Ko|dmX
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) DLi?'K3t
R&#tSL
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ d+6]u_J
L/?]^!.
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ R"+wih
;/'|WLI9
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£